2014
DOI: 10.1016/j.exppara.2014.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni

Abstract: Although its efficiency against all Schistosoma species, praziquantel (PZQ) shows low efficacy against schistosomula and juvenile stages. The potential for development of resistance to PZQ has justified the search for new alternative chemotherapies. In this scenario, studies to new formulations, more comprehensive and without adverse effects, are being conducted. One viable and promising treatment is the study of medicinal plants as a new approach to the experimental treatment for Schistosomiasis. Amongst all … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
32
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(39 citation statements)
references
References 49 publications
6
32
0
1
Order By: Relevance
“…Schistosomiasis is a neglected tropical disease, which there is no vaccine and chemotherapy relies on only PZQ (Oliveira et al 2014 In this context, G. inflata roots possess high potential for providing biologically activity compounds against parasites, such as Leishmania (Nielsen et al 1995; M A N U S C R I P T…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Schistosomiasis is a neglected tropical disease, which there is no vaccine and chemotherapy relies on only PZQ (Oliveira et al 2014 In this context, G. inflata roots possess high potential for providing biologically activity compounds against parasites, such as Leishmania (Nielsen et al 1995; M A N U S C R I P T…”
Section: Resultsmentioning
confidence: 99%
“…Then, the reliance on one single drug is alarming and emphasizes the need for research and development of novel therapeutic agents against this neglected tropical disease (Oliveira et al 2014). …”
Section: Introductionmentioning
confidence: 99%
“…Stettler et al (2004) used ABZ at 50 mg/kg against alveolar murine echinococcosis. With regard to PZQ, doses of 40 and 200 mg/kg have been evaluated for the treatment of murine schistosomiasis (de Oliveira et al, 2014). Taking into account these studies, we decided to use a dose of 50 mg/kg for both drugs.…”
Section: Discussionmentioning
confidence: 99%
“…The research on medicinal plants is encouraged by the WHO, considering that certain traditional knowledge on curative plants could add up to the development of new pharmaceutical products as well as to the combat against diseases that affects the populations of developing countries [9, 10]. …”
Section: Introductionmentioning
confidence: 99%